Several aberrations picked up on lung cancer screens are benign and harmless, but a dangerous few are not.
The latest robotic technology is poised to speed up the diagnosis and treatment of lung cancer, a new study by the American Cancer Society suggests. This could be a big win for patients who have lung cancer and are looking for easier and safer modes of treatment.
One researcher at the American Cancer Society said that lung cancer survival depends mostly on early detection. Technologies that enable doctors to diagnose and even treat disease earlier, with fewer complications, can improve survival rates.
To support this statement, an expert from Mayo Clinic Proceedings also published a journal article on April 4, 2026, in which he discussed the role of robotic technology in treating lung cancer and other cancer types. The research explained how modern technology can help locate even a small nodule using a CT scan. But he also highlighted that further research is essential to understand how to detect more common benign cases, making treatment easier and safer.
The most interesting part of the news is that this new robotic technology, commonly termed as Shape-Sensing Robotic-Assisted Bronchoscopy, was cleared for use by the U.S. Food and Drug Administration (FDA) in 2020. However, doctors began using this latest technology in recent years. With this device, doctors can easily pluck samples of lung tissue for biopsy as needed, instead of going deep into the lung several times.
Another technology, called Endobronchial Ultrasound, allows doctors to access cancer cells in the immune system glands simultaneously. The addition of high-tech 3D imaging also permits physicians to biopsy tissues with refined precision. According to an expert at the American Cancer Society, this technology has been a game-changer in lung cancer diagnosis. A new study shows that doctors have examined 2,115 lung lesions in 1,904 patients across various states, including Minnesota, Florida, and Arizona.
Since the introduction of the advanced technology of robots, the incidence rate of cases where lung cancer was diagnosed in the earlier stages has increased from 46% in 2019 to almost 69% by mid-2024, according to the scientists.
However, the incidence rate of lung cancer diagnoses during their later (riskier) stages has fallen from 54% in 2019 to 31% in 2024. Moreover, many patients receive medical care at the same time when the nodule is being examined and diagnosed. That’s because robotic bronchoscopy is often combined with treatments such as “pulsed electric field ablation,” which zaps the suspicious growth in patients not eligible for surgery or radiation.
Detecting and treating lung cancer early yields great benefits for patients. The 5-year survival rate for patients with minor tumors that have not spread is 67%, as per the researchers, compared to just 12% for patients with tumors that have metastasized.
For more interesting news and updates on cancer and its treatment procedures, follow Medipedia. We help you stay up to date on the latest news and developments in health, medication, and treatment practices.
Disclaimer:
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication or treatment.